Owl biomedical Revenue and Competitors
Estimated Revenue & Valuation
- Owl biomedical's estimated annual revenue is currently $8M per year.
- Owl biomedical's estimated revenue per employee is $251,000
Employee Data
- Owl biomedical has 32 Employees.
- Owl biomedical grew their employee count by 10% last year.
Owl biomedical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.1M | 76 | -3% | N/A | N/A |
#2 | $8M | 32 | -6% | N/A | N/A |
#3 | $5M | 20 | -9% | N/A | N/A |
#4 | $8.5M | 34 | 6% | N/A | N/A |
#5 | $5.3M | 21 | -9% | N/A | N/A |
#6 | $49.7M | 198 | 0% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $8.5M | 34 | 21% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $56.8M | 181 | -1% | $199.1M | N/A |
What Is Owl biomedical?
A company founded to advance MEMS as a sterile, live-cell sorting platform for cell therapy and cancer diagnostics. Owl biomedical, Inc. is owned by Miltenyi Biotec GmbH, a world leader in cell isolation for therapeutics and innovative research. The Owl biomedical MEMS sorting chip is at the heart of Miltenyi's flagship product, the MACSQuant Tyto. It is truly a revolution in sorting brought about by its inherent gentleness, sterility, and unparalleled ease-of-use.
keywords:N/AN/A
Total Funding
32
Number of Employees
$8M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Owl biomedical News
Their sponsors are Xiaoqian Jiang, a professor of biomedical informatics at ... Team Superb Owl earned honorable mention for its project to...
... Bio-Rad laboratories; Blue Ocean Biomedical (Acquired by Beckman Coulter) ... Owl Biomedical; Parnassus Flow Cytometry Core facility,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.3M | 34 | 21% | N/A |
#2 | $3.5M | 34 | 48% | N/A |
#3 | $5.9M | 35 | -3% | N/A |
#4 | $35M | 36 | 6% | N/A |
#5 | $10.6M | 38 | 9% | N/A |